B's Notes : company analysis, portfolio roundup

A sorry is due as I was unable to post since a while.

The previous Nykaa post seems prophetic and scenario 3 seems to have played out. The company did have a fall but the market seems to have more tolerance for Nykaa than other New gen companies. The answer lies in the free cash flow that the company generates and the nominal profit the company posts. The management seems very likeable(no controversies). Still the valuation is not something which is comfortable(maybe for me).

I am posting my portfolio for any comments that which are the companies which have reasonable valuation and scope for further growth.

company name % of portfolio
Avenue Supermarts 31.8%
P. I. Industries 12.7%
Bajaj Finance 9.4%
Clean Science & Technology 5.2%
HDFC Bank 4.8%
Pidilite Industries 3.6%
Shree Cements 3.4%
Divi’s Laboratories 3.3%
Sanofi India 2.2%
Britannia Industries 2.0%
Kotak Mahindra Bank 1.7%
Asian Paints 1.6%
Marico Limited 1.4%
Computer Age Management Services 1.3%
Caplin Point Laboratories 1.3%
Nippon India ETF Bank BeES 1.3%
Coforge 1.2%
HDFC Life Insurance Company 1.2%
Dr Lal Pathlabs 1.2%
Nippon India ETF Nifty BeES 1.1%
Procter & Gamble Hygiene 1.0%
ITC Limited 0.8%
ICICI Prudential Life Insurance Company 0.7%
Colgate-Palmolive India 0.7%
Tata Consultancy Services 0.7%
Berger Paints 0.6%
Dabur India 0.6%
HDFC Limited 0.5%
UltraTech Cement 0.5%
India Pesticides 0.4%
Nesco Limited 0.4%
ICICI Lombard General Insurance Company 0.4%
Titan Company 0.3%
Dalmia Bharat 0.3%
Max Financial Services 0.2%
Happiest Minds Technologies 0.2%
Zydus Wellness 0.1%
Hindustan Unilever 0.0%

LIC IPO Time: Meanwhile have look at this Life Insurance companies comparison